[go: up one dir, main page]

MX9604208A - Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel. - Google Patents

Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.

Info

Publication number
MX9604208A
MX9604208A MX9604208A MX9604208A MX9604208A MX 9604208 A MX9604208 A MX 9604208A MX 9604208 A MX9604208 A MX 9604208A MX 9604208 A MX9604208 A MX 9604208A MX 9604208 A MX9604208 A MX 9604208A
Authority
MX
Mexico
Prior art keywords
gel
skin
alcohol
treatment
gives
Prior art date
Application number
MX9604208A
Other languages
English (en)
Inventor
John Brown Thomsen
Jens Christian Moller
Original Assignee
John Brown Thomsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Brown Thomsen filed Critical John Brown Thomsen
Publication of MX9604208A publication Critical patent/MX9604208A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Gel para el tratamiento local de enfermedades de la piel para profilaxis, caracterizado porque contiene más del 90% de un alcohol o mezcla de alcohol de cadena corta, que coagula proteínas y/o seca, principalmente etanol y posiblemente adyuvantes o aditivos y porque contiene un agente de gelificacion, que posee buenas propiedades adhesivas para la piel, que da una formacion de matriz de alcohol o mezclas de alcohol, que crea un efecto que inhibe la evaporacion, da un efecto prolongado y forma un emplaste protector cuando el gel se ha secado.
MX9604208A 1994-03-21 1995-03-20 Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel. MX9604208A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (1)

Publication Number Publication Date
MX9604208A true MX9604208A (es) 1998-05-31

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604208A MX9604208A (es) 1994-03-21 1995-03-20 Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.

Country Status (26)

Country Link
US (4) US5981605A (es)
EP (1) EP0751789B1 (es)
JP (1) JP3560977B2 (es)
KR (1) KR100396278B1 (es)
CN (1) CN1146725A (es)
AT (1) ATE208212T1 (es)
AU (1) AU701872B2 (es)
BR (1) BR9507164A (es)
CA (1) CA2186045A1 (es)
CZ (2) CZ286758B6 (es)
DE (1) DE69523745T2 (es)
DK (1) DK0751789T3 (es)
EE (1) EE03293B1 (es)
ES (1) ES2168111T3 (es)
FI (1) FI963696A7 (es)
HU (1) HUP9774641A2 (es)
LV (1) LV12951B (es)
MX (1) MX9604208A (es)
NO (1) NO314126B1 (es)
NZ (1) NZ283135A (es)
PL (1) PL179918B1 (es)
PT (1) PT751789E (es)
RU (1) RU2142273C1 (es)
SK (1) SK281575B6 (es)
UA (1) UA41989C2 (es)
WO (1) WO1995025544A1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0751789T3 (da) * 1994-03-21 2003-09-08 Thomsen John Brown Gel til behandling af hudsygdomme og til desinfektion af huden
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
AU729078B2 (en) * 1996-06-24 2001-01-25 Bio-Safe Enterprises, Inc. Antibacterial composition
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
KR20030009454A (ko) * 2000-05-31 2003-01-29 카가쿠키쥬쯔 신코지교단 진세노사이드Ｒｂ1으로 된 피부조직 재생촉진제
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
RU2199325C2 (ru) * 2001-02-26 2003-02-27 Бежин Александр Иванович Способ профилактики интраоперационного высыхания брюшины при операциях на органах брюшной полости
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
AU2005337121A1 (en) * 2004-12-09 2007-04-19 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
EP2034826A2 (en) * 2006-06-02 2009-03-18 The Dial Corporation Method of inhibiting the transmission of influenza virus
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
WO2008049454A1 (en) 2006-10-23 2008-05-02 Ecolab Inc. Virucidal composition
CA2671615A1 (en) * 2006-12-04 2008-06-12 Smithkline Beecham Corporation Topical pharmaceutical composition
JP5028131B2 (ja) * 2007-04-13 2012-09-19 花王株式会社 ゲル化剤
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2008153748A1 (en) * 2007-05-24 2008-12-18 The Mclean Hospital Corporation Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (de) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
RU2355394C1 (ru) * 2007-08-14 2009-05-20 Павел Анатольевич Лощаков Средство для профилактики и лечения высыпаний герпеса на губах и коже людей
RU2369382C1 (ru) * 2008-03-05 2009-10-10 Павел Анатольевич Лощаков Средство для профилактики и лечения высыпаний герпеса на губах и коже людей
EA013233B1 (ru) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
US9554994B2 (en) * 2009-12-16 2017-01-31 Ecolab Usa Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation
JP7655568B2 (ja) * 2019-10-25 2025-04-02 ムココルト アクチエボラグ 粘膜又は皮膚における炎症状態の治療

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (de) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Verfahren zur Herstellung von in Wasser und/oder Alkali loeslichen Celluloseaethern
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (de) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach Viruzides mittel
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (fr) * 1987-04-10 1990-06-29 Roussel Uclaf Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
AU653248B2 (en) * 1991-06-20 1994-09-22 Cep Holdings, Inc. Topical composition enhancing healing of herpes lesions
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
DK0751789T3 (da) * 1994-03-21 2003-09-08 Thomsen John Brown Gel til behandling af hudsygdomme og til desinfektion af huden
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
EE03293B1 (et) 2000-10-16
HUP9774641A2 (en) 1997-01-28
PT751789E (pt) 2002-04-29
EP0751789A1 (en) 1997-01-08
US5981605A (en) 1999-11-09
CZ288150B6 (en) 2001-05-16
SK281575B6 (sk) 2001-05-10
DK0751789T3 (da) 2003-09-08
US20040054015A1 (en) 2004-03-18
SK119496A3 (en) 1997-06-04
CA2186045A1 (en) 1995-09-28
CZ286758B6 (en) 2000-06-14
US20020086905A1 (en) 2002-07-04
CZ272396A3 (en) 1997-06-11
NO963971D0 (no) 1996-09-20
FI963696L (fi) 1996-11-07
KR100396278B1 (ko) 2003-11-28
FI963696A7 (fi) 1996-11-07
JP3560977B2 (ja) 2004-09-02
FI963696A0 (fi) 1996-09-18
WO1995025544A1 (en) 1995-09-28
DE69523745T2 (de) 2002-08-08
NO963971L (no) 1996-11-19
HU9602583D0 (en) 1996-11-28
AU2109995A (en) 1995-10-09
PL179918B1 (pl) 2000-11-30
JPH09510468A (ja) 1997-10-21
PL316651A1 (en) 1997-02-03
NO314126B1 (no) 2003-02-03
CN1146725A (zh) 1997-04-02
AU701872B2 (en) 1999-02-11
US6342537B1 (en) 2002-01-29
ES2168111T3 (es) 2002-06-01
DE69523745D1 (de) 2001-12-13
RU2142273C1 (ru) 1999-12-10
ATE208212T1 (de) 2001-11-15
NZ283135A (en) 2004-12-24
BR9507164A (pt) 1997-09-09
EP0751789B1 (en) 2001-11-07
LV12951B (en) 2003-05-20
UA41989C2 (uk) 2001-10-15

Similar Documents

Publication Publication Date Title
MX9604208A (es) Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ES2154336T3 (es) Producto para el cuidado de la piel.
ES2073205T3 (es) Agentes con efecto refrigerante fisiologico y compuestos activos apropiados para estos agentes.
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
GEP20002332B (en) Cefalosporin Derivatives
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DE69921119D1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
ES2096743T3 (es) Nuevas composiciones.
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
TR200100637T2 (tr) Yeni doğal ürün türevleri
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
AR029829A1 (es) Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel
MX2023007969A (es) Tratamiento en gel para desinfeccion y enfermedad de la piel

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: ASSE THOMSEN

MM Annulment or lapse due to non-payment of fees